somatic mutations as markers of outcome after azacitidine and allogenic stem cell transplantation in higher risk myelodysplastic syndromes

Simona Sica*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Fingerprint

Entra nei temi di ricerca di 'somatic mutations as markers of outcome after azacitidine and allogenic stem cell transplantation in higher risk myelodysplastic syndromes'. Insieme formano una fingerprint unica.

Medicine and Dentistry